Drug Interactions

Ulipristal plasma concentration and pharmacologic effects may be decreased. Monitor the clinical response and adjust the ulipristal dose as needed.

CYP3A4 inhibitors (eg, itraconazole, ketoconazole)

Ulipristal plasma concentrations may be elevated, increasing the pharmacologic effects and risk of adverse reactions. Monitor the clinical response and adjust the ulipristal dose as needed.

Adverse Reactions

CNS

Headache (19%); fatigue (6%); dizziness (5%).

Dermatologic

Acne (postmarketing).

GI

Abdominal and upper abdominal pain (15%); nausea (13%).

Genitourinary

Dysmenorrhea (13%).

Precautions

Monitor

Evaluate patients who complain of lower abdominal pain for the possibility of ectopic pregnancy. A follow-up physical or pelvic examination is recommended if there is any doubt concerning the general health or pregnancy status of any woman after taking ulipristal.

Pregnancy

Category X . Not effective in terminating an existing pregnancy.

Lactation

Undetermined. Use is not recommended.

Children

Use before menarche is not indicated.

Elderly

Not intended for use in postmenopausal women.

Ectopic pregnancy

May occur. Consider ectopic pregnancy in women who become pregnant or complain of lower abdominal pain.

Existing pregnancy

Not indicated for termination of an existing pregnancy.

Fertility following use

A rapid return of fertility is likely following treatment; therefore, continue or initiate routine contraception as soon as possible.

Menstrual cycle effects

Menses may occur earlier or later than expected by a few days.

Repeated use

Repeated use within the same menstrual cycle is not recommended.

STDs

Does not protect against HIV (AIDS) and other STDs.

Overdosage

Symptoms

None well documented.

Patient Information

Instruct patients to take as soon as possible and not more than 120 h after unprotected intercourse or known or suspected contraceptive failure.

Advise patients that if vomiting occurs within 3 h of taking ulipristal to immediately contact their health care provider to discuss whether to take another tablet.

Advise patient to seek medical attention if severe lower abdominal pain occurs 3 to 5 wk after taking ulipristal in order to rule out ectopic pregnancy, or if their period is delayed more than 1 wk beyond the date expected after taking emergency contraceptives.

Advise patients to not take this medication if they know or suspect they are pregnant and that this medication is not indicated for termination of an existing pregnancy.

Inform patients that this medication is not to be used as routine contraception and not to use it repeatedly within the same menstrual cycle.

Inform patients that this medication may reduce the contraceptive action of regular hormonal contraceptive methods and to use a reliable barrier method of contraception for any subsequent acts of intercourse that occur during that same menstrual cycle.

Advise patients not to use this medication if they are breast-feeding.

Inform patients that this medication does not protect against HIV infection (AIDS) and other STDs.

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment.